A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension - Concepedia

Concepedia

Publication | Open Access

A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension

DOI Full Paper Access

68

Citations

0

References

2007

Year

Arun Narayanaswamy, Aditya Neog, Mani Baskaran, Ronnie George, Vijaya Lingam, Chetan Desai, Viraj Rajadhyaksha

Indian Journal of Ophthalmology

Abstract

The magnitude of IOP lowering in patients with POAG and OH with Xalatan and Latoprost is different. In our study, the IOP lowering with Xalatan was higher than that with Latoprost.